← SynDRA
OMIPALISIB
SynDRA canonical compound SYN0024404 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MTOR | PIK3CA | PIK3CB | PIK3CD | PIK3CG |
|---|
| Mechanism of action | mTOR inhibitor | PI3K inhibitor |
|---|
All known targets
- MTOR
- PIK3CG
- PIK3CA
- PIK3CB
- PIK3CD
Mechanisms of action (all sources)
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- PI3K inhibitor
- PIK3CG MODULATOR
Cross-references
Synonyms
- GSK-2126458
- GSK2126458
- GSK 2126458
- UNII-1X8F5A3NA0
- 2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide
- 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide
- 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- 1X8F5A3NA0
- Omipalisib (GSK2126458, GSK458)
- C25H17F2N5O3S
- Omipalisib [USAN:INN]
- GSK 212
- 2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide
- Benzenesulfonamide, 2,4-difluoro-N-(2-methoxy-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)-
- 2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzenesulfonamide
- GSK458
- 2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide
- OMIPALISIB [INN]
- Omipalisib (USAN/INN)
- OMIPALISIB [USAN]
- OMIPALISIB [WHO-DD]
- MLS006011258
- Omipalisib; GSK2126458
- SCHEMBL623194
- GTPL8974
- Omipalisib (GSK2126458)
- CHEMBL1236962
- CHEBI:95093
- DTXSID10148604
- EX-A003
- GSK-458
- 3l08
- HMS3656D09
- BCP02252
- BDBM50145416
- MFCD16038929
- NSC764092
- NSC800807
- s2658
Look up OMIPALISIB in the interactive SynDRA portal →